Browse 161 schizophrenia clinical trials enrolling across the United States and Canada. 84 people applied to schizophrenia studies last month. Search by city or state to find one near you.
Filter
1
Filter results
Results: 161
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
for
Schizophrenia
Location: South Dartmouth MA, Boston MA, New York NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07101094
Recruiting
A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
for
Schizophrenia
Location: Marlton NJ, Hollywood FL, Miami Lakes FL, Decatur GA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 55
Code: NCT07061288
Phase1, Recruiting
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
for
Cognitive Impairment Associated With Schizophrenia (CIAS)
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning